Evaluating the relationship between serum level of interleukin-6 and rheumatoid arthritis severity and disease activity.
The aim of this study was to evaluate the relationship between Interlukin-6 (IL-6) serum level and the severity and activity of RA. In this cross-sectional study, 120 RA patients referred to the rheumatology clinic, the patients were diagnosed by rheumatologists according to ACR / EULAR 2010 criteria. Based on Based on DAS28 score the patients were divided into 4 groups: Remission, Mild, Moderate and Severe. Each group contained 30 patients. Serum levels of ESR, CRP, anti-cyclic citrullinated peptide (anti-CCP) and RF, as well as serum levels of IL-6, were measured in these patients. Then, the relationship between these factors in the four groups was measured and compared, and the relationship between IL-6 and these factors, and especially the severity of the disease, was evaluated based on DAS-28. This study showed that the serum level of IL-6 has a significant relationship with RA severity according to DAS-28 (P value <0.001). There is also a significant relationship between the ESR level, the number of painful joints, and the number of the swollen joints, and the severity of the disease based on VAS. generally the findings of this study indicate that serum levels of IL-6 plays an important role in the severity and activity of RA disease and can be considered as a determining factor in evaluating severity of RA in RA patients and it is a good guide for step up or down of treatment.